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It has been known for a long time that excessive
consumption of alcohol has adverse effects, including
adverse impact on kidneys and kidney disease. Recently,
observational evidence has been provided that moderate
alcohol consumption is associated with less cardiovascular
and renal risk. These issues had been summarized and
discussed at the recent congress of the European Society
for Biomedical Research and Alcoholism in Vienna.
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On occasion of the recent congress of the European Society
for Biomedical Research on Alcoholism (ESBRA) in Vienna,
4–7 September 2011, one entire session had been devoted to
the relationship between alcohol and the kidney. It was the
goal of this session to provide an evenhanded analysis of the
impact of alcohol consumption on the evolution of chronic
kidney function and disease. The interest in the issue of
alcohol and its effect on the kidney was aroused by the fact
that—after several preceding negative analyses1,2—a number
of stringent prospective observational studies had recently
documented that moderate alcohol consumption has a
beneficial effect both on the decline in renal function with
age and the evolution of primary kidney disease.3–6 The fact
that one major session of the congress was devoted to the
kidney indicates that these novel findings had a resonance
even outside of nephrology. This was also reflected by an
animated and constructive discussion.
The documentation that moderate alcohol consumption
retards progression of CKD is of interest because currently
available interventions, e.g., RAS blockade, mineralocorti-
coid receptor blockade, endothelin receptor blockade,
antioxidant anti-inflammation modulation, although un-
doubtedly reducing progression, fail to completely stop
progression of CKD so that any additional additive measure
is welcome.
Adverse renal effects of alcohol
Since the nineteenth century, it has been known that
alcoholism is associated with a higher risk of glomerulone-
phritis as reported by Frerichs7,8 and many others. Recent
reports also document that even today alcoholism remains a
risk factor for post-infectious glomerulonephritis,9,10 acute
kidney injury,11 and kidney graft failure,12 and the only
positive aspect was that alcohol consumption was associated
with less renal cell carcinoma.13
Moderate alcohol consumption and chronic cardiovacular
disease
In the past two decades the beneficial effect of moderate
consumption of alcohol on mortality14 has been well
documented, including specifically the reduction of cardio-
vascular mortality, e.g., in the health professional follow-up
study,15 as well as the beneficial effects on the outcome of
myocardial infarction16 or heart failure.17 A beneficial effect
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on non-cardiovascular outcomes such as cognitive impair-
ment18 has been documented in observational studies as well.
Information on the effect of alcohol on renal disease,
however, had almost been absent for a considerable time.
The beneficial effect of alcohol is clearly dose dependent
and differs between men and women; the latter have lower
hepatic alcohol dehydrogenase activity, but a beneficial effect
of alcohol is demonstrable even in women up to an intake of
B25 g alcohol per day compared withB45 g alcohol per day
in men.19 However, it is interesting to note that—with the
interesting exception of Type 2 diabetes—the CV benefit is
demonstrable only in those women over the age of 50 years.20
There has been a long-standing discussion whether all
alcohol is created equal or whether wine, specifically red wine,
differs from other types of alcohol. It appears that red wine
provides additional coronary protection and that in general
wine provides more cardiovascular protection than beer.21
Moderate alcohol consumption and diabetes
Given the fact that diabetic nephropathy has become the
single most common cause of renal failure, it is of
considerable interest that alcohol consumption decreases
the risk of developing Type 2 diabetes; e.g., in the nurses’
health study, daily alcohol consumption of 5.1–10 g per day
reduced the risk of new-onset Type 2 diabetes significantly
(relative risk 0.56; 0.48–0.65).22
In type 1 diabetic individuals as well, the EURODIAB
prospective complications study23 showed that daily con-
sumption of 30–70 g alcohol per week reduced the odds ratio
(OR) of macroalbuminuria to 0.36.
Moderate alcohol consumption and kidney
Although some early epidemiological studies on alcohol and
progression of nondiabetic renal disease failed to provide
documentation of a benefit in CKD,1,2 more recent large and
well-designed studies document a beneficial effect of
moderate alcohol consumption on loss of renal function
not only in individuals with kidney disease but also in
individuals without primary kidney disease, particularly
elderly individuals. In a prospective study in 11,023 healthy
men with 14 years of follow-up, Schaeffner4 found that men
who consumed at least seven drinks weekly had an OR of
0.71 to develop new onset of renal dysfunction, defined as
serum creatinine X1.5 mg/dl, compared with men who
consumed p1 drink per week. A study on individuals with
no primary kidney disease compared the impact of self-
reported consumption of o30 g alcohol per day with 430 g
alcohol per day on the development of albuminuria and
estimated glomular filtration rate (eGFR) o60 ml/min; the
ORs for new onset of albuminuria was 1.59 and for eGFR
o60 ml/min 0.59.3 The discrepancy between the behavior of
albuminuria and eGFR remains unexplained.
Recent studies show that moderate alcohol consumption
attenuates progression and loss of GFR in patients with
primary kidney disease as well. A Finnish study5 examined
158 individuals with IgA glomerulonephritis: in the cross-
sectional arm (158 patients), proteinuria was lower in light
and moderate drinkers, and their creatinine clearance was
higher than in abstainers and heavy drinkers; in the
longitudinal arm, the OR was 0.4 in light drinkers, 0.1 in
moderate drinkers, but increased in heavy drinkers (2.3)
compared with abstainers (OR 1.0) displaying a J-shaped
relationship. The authors suggested that a daily alcohol
intake of 11–27 g alcohol was optimal with respect to renal
function in women and 11–40 g alcohol was optimal in men.
The strongest association for a beneficial effect of alcohol
on progression of CKD to ESRD was provided by Reynolds.6
During 9 years of follow-up, the cumulative incidence of
‘onset of ESRD’ was 35.7 per 100,000 person years in
abstainers; it was 21.1 in individuals who consumed
o3 drinks per day and 17.1 in individuals who consumed
43 drinks per day (OR 0.45).
Such beneficial effect is remarkable in view of the well-
known fact that high alcohol consumption is associated with
higher blood pressure values. However, this cannot necessa-
rily be extrapolated to moderate alcohol use. A study by
Renaud24 recently showed that at least moderate wine
drinkers, not necessarily beer drinkers, had lower blood
pressure values and lower all-cause mortality. Given the high
cardiovascular risk of CKD patients, it is further interesting
to note that in the Cardiovascular Health Study alcohol use
was the only characteristic that was associated with a lower
cardiovascular risk in CKD patients.25
In recipients of a renal transplant, less de novo diabetes
and mortality was noted in individuals with moderate
alcohol consumption.26 At least in animal experiments,
polyphenols and quercetin in wine reduced cyclosporine
nephrotoxicity by antagonizing oxidative stress–dependent
renal damage.27
What are the underlying mechanisms?
It has been argued that alcohol consumption is associated
with less hyalinization of arterioles in renal tissue.28 At least
in animal studies, evidence was provided that polyphenols
function as ROS scavengers and metal chelators; furthermore,
ethanol increases the activity of antioxidant enzymes29 as
shown in the model of glycerol injection rhabdomyolysis
with acute renal failure; moreover, less lipid peroxidation
(malondialdeyde) and less protein oxidation (carbonyl
content) had been shown. A further mechanism is the
effect of resveratrol on sirtuin, which deacetylates and
inactivates p53.21
Practical considerations
Human nature being what it is, it will be a challenge to always
find the right balance between health benefit from moderate
alcohol consumption and alcohol-induced renal pathology
from addiction. In view of the Janus-faced role of alcohol—
beneficial at moderate and deleterious at high consump-
tion—a balanced approach in the management of patients
with CKD and of elderly individuals with progressive loss of
renal function is appropriate.
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